scispace - formally typeset
Search or ask a question

Showing papers in "Journal of Affective Disorders in 2014"


Journal ArticleDOI
TL;DR: In this article, the authors conducted a systematic review of parental factors associated with depression and anxiety disorders in young people which parents can potentially modify, including less warmth, more inter-parental conflict, over-involvement, and aversiveness; and additionally, they include less autonomy granting and monitoring.

434 citations


Journal ArticleDOI
TL;DR: It is suggested that maternal anxiety during pregnancy was positively related to an increased risk of PTB and LBW and healthcare providers should give close attention to anxiety in pregnant women and provide appropriate mental health support in order to improve outcomes for both mothers and infants.

392 citations


Journal ArticleDOI
TL;DR: Psychotherapy contributes to improvement in depressed patients, but improvement in control conditions is also considerable, and less than half of the patients meeting criteria for response and remission after psychotherapy are found.

362 citations


Journal ArticleDOI
TL;DR: There is significant evidence that inflammatory processes influence the development and progression of MDD and future studies with larger arrays of cytokine profiles aided by neuroimaging may provide more sensitive and specific modes of diagnostics in determining MDD etiology and provide guidance in individual therapies.

327 citations


Journal ArticleDOI
TL;DR: The pathoetiological heterogeneity of MDD/TRD invites the need for mechanistically dissimilar, and empirically validated, treatment approaches for TRD.

322 citations


Journal ArticleDOI
TL;DR: The findings support the validity of the Brazilian Portuguese version of the DASS-21 and add to the evidence of the dass-21 quality and ability to assess emotional states separately, eliminating the use of different instruments to assess these states.

317 citations


Journal ArticleDOI
TL;DR: This study shows that an internet-based intervention for depression is equally beneficial to regular face-to-face therapy, however, more long term efficacy, indicated by continued symptom reduction three months after treatment, could be found for the online group.

253 citations


Journal ArticleDOI
TL;DR: New strategies that target cognitive symptoms of depression in addition to mood symptoms are needed to improve long-term outcomes, particularly functional recovery.

248 citations


Journal ArticleDOI
TL;DR: Future health education campaigns or self-help prevention interventions targeting adolescent depression should aim to reduce substance use; dieting; and negative coping strategies; and promote healthy weight; diet; and sleep patterns.

248 citations


Journal ArticleDOI
TL;DR: Adolescent anxiety, compared to childhood anxiety, is associated with more adverse psychosocial outcomes at age 30, and adult anxiety, SUD, alcohol abuse/dependence, and anxiety mediated the association between adolescent anxiety and most domains of psychossocial functioning at age30.

229 citations


Journal ArticleDOI
TL;DR: Prospective, mechanistic investigations are critically needed to understand why intra-infusion dissociation correlates with a more robust antidepressant efficacy of ketamine.

Journal ArticleDOI
TL;DR: Main gender differences in the clinical presentation of MDD concerned a younger age of onset, higher anxiety and lower alcohol use comorbidity and higher prevalence of atypical depression in women, accompanied by differences in health care use.

Journal ArticleDOI
TL;DR: Benefits of social identification were larger for depression symptoms than for anxiety symptoms or quality of life, suggesting that facilitating social participation is effective and cost-effective in treating depression.

Journal ArticleDOI
TL;DR: It is suggested that the effect sizes of ICBT for depression are at least as high when the treatment is delivered in routine psychiatric care by qualified staff as when delivered in a controlled trial setting.

Journal ArticleDOI
TL;DR: Safety and efficacy of repeated ketamine infusions were attained without medication-free state in patients with TRD, and repeated infusions achieved superior antidepressant outcomes as compared to a single infusion with different trajectories of response and remission.

Journal ArticleDOI
TL;DR: CCT and tDCS combined might be beneficial for older depressed patients, particularly for those who have cognitive resources to adequately learn and improve task performance over time, and specifically relevant in this subgroup that is more prone to present cognitive decline and prefrontal cortical atrophy.

Journal ArticleDOI
TL;DR: There is evidence of seasonality in BD, with emerging evidence that climatic conditions may trigger BD symptoms or episodes, and there was evidence for greater seasonal fluctuations in mood and behavior in individuals with BD than in those with unipolar depression or 'healthy' controls.

Journal ArticleDOI
TL;DR: The Patient Health Questionnaire-9 showed reasonable accuracy in classifying cases of depression, was easily implemented by lay health workers, and is a useful screening tool in this setting.

Journal ArticleDOI
TL;DR: It is concluded that olfaction is a marker for depression in humans, however, the results are limited to a relatively selective sample of depressed women.

Journal ArticleDOI
TL;DR: Emotion dysregulation seems to be an important cognitive dysfunction in GAD patients and fMRI studies suggest that it is related to PFC and ACC hypofunction as well as a deficient cortex-amygdala functional connectivity.

Journal ArticleDOI
TL;DR: The findings support the predominance of depressive symptoms compared with mood elevation/mixed symptoms in the course of bipolar illness, and thus an overall greater burden in terms of economic costs, functioning, caregiver burden, and suicide.

Journal ArticleDOI
TL;DR: The results support the use of the WHO-5 in the context of depression research as a measure of well-being and demonstrate strong measurement invariance regarding the presence or absence of a current MDE.

Journal ArticleDOI
TL;DR: Current and future research studies are using ketamine as a promising tool to evaluate the glutamatergic neurotransmittor system to learn more about the pathophysiology of depression and develop more specific rapid-acting antidepressant treatments.

Journal ArticleDOI
TL;DR: There is evidence highlighting the importance of a reduced no-treatment interval for patients suffering Unipolar Depression, with emphasis on the first episode of depression corresponding to the notion of reducing the duration of untreated illness.

Journal ArticleDOI
TL;DR: A meta-analysis found personality disorders are common in mood disorders and moderator analyses showed higher comorbidity when diagnoses were based on questionnaires versus clinical interviews, DSM-III-R versus DSM-IV, more women were included or the duration of the disorder was longer.

Journal ArticleDOI
TL;DR: Adjunctive psychological treatments can improve BD outcomes and several moderators and mediators have been identified but more research is needed to design shorter but effective interventions tailored to the characteristics of the target population.

Journal ArticleDOI
TL;DR: The overview of demographic and clinical characteristics provided by this review may help medical professionals distinguish between major depressive disorder and bipolar disorder.

Journal ArticleDOI
TL;DR: PTSD and depression are each associated with suicidality independently and in combination in the active duty component of the U.S. Army.

Journal ArticleDOI
TL;DR: In this paper, the authors investigated the association between childhood adversity, depressive symptoms and clinical course in treatment-resistant depression patients and found that childhood adversity was associated with poorer clinical course, including earlier age of onset, episode persistence and recurrence.

Journal ArticleDOI
TL;DR: In this paper, a randomised, double-blind, placebo-controlled study, 56 individuals with major depressive disorder were treated with curcumin (500 mg twice daily) or placebo for 8 weeks.